Acumen Pharmaceuticals, Inc. (ABOS) insider trading

By person

15 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Daniel Joseph OConnell

Chief Executive Officer

—

881,275

$2.05M

+75.4%

Matt Zuga

CFO & Chief Business Officer

—

304,924

$708.95K

+44.2%

Eric Siemers

Chief Medical Officer

—

255,371

$593.74K

+117.2%

James J. Doherty

President and CDO

—

220,900

$513.59K

—

John A Stalfort III

Director

—

220,624

$512.95K

+28.0%

Russell Barton

Chief Operating Officer

—

205,092

$476.84K

+111.7%

Derek M Meisner

Chief Legal Officer & Corp Sec

—

173,999

$404.55K

+59.8%

Amy Schacterle

Chief Regulatory Officer

—

92,303

$214.60K

—

Ra Capital Management, L.p. entity

Director

—

48,300

$112.30K

—

Kimberlee C Drapkin

Director

—

48,300

$112.30K

—

Laura Stoppel

Director

—

48,300

$112.30K

—

Jeffrey L. Ives

Director

—

48,300

$112.30K

—

Nathan B Fountain

Director

—

48,150

$111.95K

+670.4%

George Golumbeski

Director

—

35,500

$82.54K

—

Derrell Porter

Director

—

35,500

$82.54K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Acumen Pharmaceuticals, Inc.

What the insiders did No buying or selling

By person